ArticleThe Journal of dermatology2026

Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.

Mizuki Shiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.